Last reviewed · How we verify
NCT04988711: HbOxymeter
Non-invasive Tool for Measuring Hemoglobin in Severe Trauma Patients in the ED
NA trial testing Hb Oxymeter in Trauma in 100 participants. Completed in 1 May 2021.
30 April 2021
Quick facts
| Lead sponsor | Hôpital Universitaire Sahloul |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 100 |
| Start date | 1 August 2017 |
| Primary completion | 30 April 2021 |
| Estimated completion | 1 May 2021 |
| Sites | 2 locations across Tunisia |
Drugs / interventions tested
- Hb Oxymeter
Conditions studied
- Trauma — all drugs for Trauma →
Sponsor
Hôpital Universitaire Sahloul — full company profile →
Who can join
4 and older, any sex, with Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The development of miniaturized analytical technologies has facilitated the gradual decentralization of part of the laboratory examinations to the patient. In addition, investigators are currently seeing the development of tools for non-invasive measurement of certain biological parameters. Thanks to their ease of use, results are obtained almost immediately and with good performance. These "rapid" tests or techniques should, in theory, reduce the time taken to take charge of patients, particularly in emergencies or in critical situations where the therapeutic decision should be as rapid and efficient as possible. These means, by their ease and speed of results, could be associated with the clinical examination of the practitioner to increase his diagnostic performance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04988711
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Trauma
Currently open trials in the same condition.
- NCT07290634 — Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion · recruiting
- NCT07485231 — Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD · NA · recruiting
- NCT07473336 — The Effectiveness of RAPID-Based Psychological First Aid Training · NA · active not recruiting
- NCT07278505 — Study of Cannabidiol and Neuroimaging on Stress · Phase 1, PHASE2 · recruiting
- NCT02880163 — REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NA · recruiting
Other Hôpital Universitaire Sahloul trials
Trials by the same sponsor.
- NCT07329881 — Artificial Intelligence Algorithm for the Interpretation of Traumatic Bone Radiographs · active not recruiting
- NCT07147699 — Evaluation of the Effectiveness of the CardioStory Device in Distinguishing Heart Failure From Other Causes in Patients · not yet recruiting
- NCT07089277 — External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population · recruiting
- NCT06953154 — Monocyte Distribution Width (MDW): An Early Marker of Sepsis in Patients With Comorbidities · completed
- NCT05646433 — Validation of a New Score for UGI Bleeding in the ED: the Study of the TU-GIB Score · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04988711 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hôpital Universitaire Sahloul
- Last refreshed: 3 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04988711.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing